melatonin has been researched along with Ischemia in 61 studies
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Excerpt | Relevance | Reference |
---|---|---|
"These studies demonstrate a significant neuroprotective efficacy of melatonin in term neonatal models of hypoxia-ischaemia, and suggest melatonin is a strong candidate for translation to clinical trials in babies with moderate-severe NE." | 9.22 | Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia. ( Golay, X; Han, HJ; Meehan, C; Miller, SL; Pang, R; Robertson, NJ, 2022) |
"Melatonin promptly reversed ischemia-induced sleep disturbances." | 8.02 | Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats. ( Hao, SM; Huang, ZL; Qiu, MH; Qu, WM; Sun, FY; Zhong, ZG, 2021) |
"The current study compared the impact of pretreatment with melatonin and N-acetylcysteine (NAC) on the prevention of rat lung damage following intestinal ischemia-reperfusion (iIR)." | 8.02 | Melatonin can be, more effective than N-acetylcysteine, protecting acute lung injury induced by intestinal ischemia-reperfusion in rat model. ( Brandão, JCM; Camargo, CR; Leite, AA; Marinho, M; Oliveira-Junior, IS; Reiter, RJ; Sakae, TM, 2021) |
" To address this, we investigated the effect of melatonin on ischemia-induced fibrosis." | 7.96 | Melatonin suppresses ischemia-induced fibrosis by regulating miR-149. ( Han, YS; Lee, JH; Lee, SH, 2020) |
"The article studies the effect of melatonin on the intensity of free radical oxidation, the functioning of the enzymatic components of the antioxidant system and their transcriptional regulation in rats with experimental cerebral ischemia/reperfusion of the brain." | 7.91 | Transcriptional Regulation of Antioxidant Enzymes Activity and Modulation of Oxidative Stress by Melatonin in Rats Under Cerebral Ischemia / Reperfusion Conditions. ( de Carvalho, MAP; Kryl'skii, ED; Popova, TN; Razuvaev, GA; Safonova, OA; Stolyarova, AO, 2019) |
" Study groups were formed as follows: (1) control group, (2) ischemia group, (3) selenium + ischemia group, (4) melatonin + ischemia group, and (5) selenium + melatonin + ischemia group." | 7.91 | Effects of Selenium and Melatonin on Ocular Ischemic Syndrome. ( Telek, HH, 2019) |
"We tested the hypothesis that daily melatonin treatment protects endothelial lineage and functional integrity against the aging process, oxidative stress/endothelial denudation (ED), and toxic environment and restored blood flow in murine critical limb ischemia (CLI)." | 7.88 | Daily melatonin protects the endothelial lineage and functional integrity against the aging process, oxidative stress, and toxic environment and restores blood flow in critical limb ischemia area in mice. ( Chai, HT; Chen, KH; Chen, YL; Chua, S; Chung, SY; Huang, CR; Huang, TH; Lee, FY; Li, YC; Luo, CW; Sheu, JJ; Sun, CK; Sung, PH; Yip, HK, 2018) |
"Aortic occlusion, Injury, Ischemia/Reperfusion, Liver, Melatonin." | 7.83 | The protective effect of melatonin on remote organ liver ischemia and reperfusion injury following aortic clamping. ( Adali, F; Bali, A; Celep, RB; Celik, S; Gonul, Y; Koçak, A; Ozkececi, ZT; Ozsoy, M; Tosun, M, 2016) |
"Treatment with melatonin reduced/prevented functional and morphological changes induced by chronic ischemia on penile structure and function." | 7.83 | Melatonin Improves Erectile Function in Rats With Chronic Lower Body Ischemia. ( Andersson, KE; Mitsui, T; Nomiya, M; Sawada, N; Takeda, M; Zarifpour, M, 2016) |
"Melatonin exerts a protective effect during hepatic ischemia-reperfusion (I/R) injury through modulation of the apoptotic cell death program." | 7.81 | Melatonin attenuates hepatic ischemia through mitogen-activated protein kinase signaling. ( Gim, SA; Koh, PO, 2015) |
"This experimental study was designed to produce ischemia-reperfusion (I/R) injury in rat corpus cavernosum by inducing 1 h of priapism and investigating the effects of melatonin on the levels of oxidative injury parameters." | 7.76 | An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis. ( Akbas, A; Atılgan, D; Erdemir, F; Erkorkmaz, U; Parlaktas, BS; Uluocak, N; Yasar, A, 2010) |
"The effect of melatonin on reperfusion arrhythmias and postischemic contractile dysfunction was studied in the isolated rat heart." | 7.73 | Ischemia-reperfusion injury--antiarrhythmic effect of melatonin associated with reduced recovering of contractility. ( Béder, I; Pancza, D; Styk, J; Vazan, R, 2005) |
" melatonin (4 + 4 mg/kg, after induction of ischemia and at reperfusion onset) administered either alone or in combination with the thrombolytic tissue-plasminogen activator (t-PA, 10 mg/kg), on cerebral laser Doppler flow (LDF) and ischemic injury were studied after 30 min of middle cerebral artery (MCA) thread occlusion in male C57BL/6 mice." | 7.72 | Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator. ( Hermann, DM; Kilic, E; Kilic, U; Reiter, RJ; Yulug, B, 2004) |
"This study was designed to study the effects of Melatonin (Mel) and N-Acetylcystein (NAC) on hepatic ischemia/reperfusion (I/R) injury in rats." | 7.72 | Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. ( Arbak, S; Ayanoğlu-Dülger, G; Ersoy, Y; Kaçmaz, A; Sehirli, AO; Sener, G; Tosun, O, 2003) |
" Herein, we examined the effect of melatonin on the neutrophil apoptosis in ischemia and reperfusion of the human liver." | 7.72 | Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion. ( Chen, HM; Chen, JC; Chiu, TF; Ng, CJ, 2003) |
"As a potent free radical scavenger and antioxidant, melatonin protects brain tissue against ischemia-reperfusion injury, partly via suppression of ischemia-induced production of nitric oxide, when given before ischemia-reperfusion or within 2 hr of onset of ischemia." | 7.72 | Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation. ( Cheung, RT; Pei, Z, 2003) |
"Finally, hemodynamic index changes, infarct size, CK-MB levels, mitochondrial functional endpoints, and expression of mitochondrial biogenesis genes (SIRT-1/PGC-1α/NRF-2/TFAM) were assessed." | 5.91 | Melatonin/nicotinamide mononucleotide/ubiquinol: a cocktail providing superior cardioprotection against ischemia/reperfusion injury in a common co-morbidities modelled rat. ( Badalzadeh, R; Chodari, L; Ghaffari, S; Høilund-Carlsen, PF; Mokhtari, B; Yasami, M, 2023) |
"Melatonin (15 mg/kg) was administered 5 min after HI." | 5.91 | MiR-126 and miR-146a as Melatonin-Responsive Biomarkers for Neonatal Brain Ischemia. ( Albertini, MC; Balduini, W; Buonocore, G; Carloni, S; Dell'Orto, V; Perrone, S; Vanzolini, T; Weiss, MD, 2023) |
"Melatonin treatment reversed the harmful effects of hyperglycemia on EPC through adenosine monophosphate-activated protein kinase-related mechanisms to increase eNOS phosphorylation and heme oxygenase-1 expression." | 5.72 | Melatonin Improves Ischemia-Induced Circulation Recovery Impairment in Mice with Streptozotocin-Induced Diabetes by Improving the Endothelial Progenitor Cells Functioning. ( Chen, CY; Chou, RH; Huang, HL; Huang, PH; Kuo, CS; Lin, SJ; Tsai, HY; Wei, JH, 2022) |
"Melatonin treatment significantly inhibited the above changes through modulating α7nAChR." | 5.72 | Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss. ( Chen, S; Hu, X; Jin, X; Li, F; Li, H; Li, Y; Liu, W; Sun, Y; Zhang, J; Zhang, X; Zhao, X; Zheng, GQ, 2022) |
"Retinopathy of prematurity is a vision-threatening disease associated with retinal hypoxia-ischemia, leading to the death of retinal neurons and chronic neuronal degeneration." | 5.62 | Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. ( Cui, K; Huang, R; Liang, X; Lin, J; Liu, Y; Lu, X; Shi, Y; Tang, X; Xu, Y; Ye, D; Yu, S, 2021) |
"Melatonin is a free radical scavenger and broad-spectrum antioxidant with immunomodulatory effects." | 5.42 | Melatonin prevents lung injury induced by hepatic ischemia-reperfusion through anti-inflammatory and anti-apoptosis effects. ( An, H; Jiang, C; Yang, B; Zhang, H; Zhao, D; Zhou, L, 2015) |
"Melatonin has been widely studied as a protective agent against oxidative stress." | 5.40 | Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression. ( Buendia, I; Cuadrado, A; Egea, J; León, R; López, MG; Negredo, P; Parada, E; Romero, A, 2014) |
"Melatonin augmented the increase in the eNOS mRNA level, whereas it reduced the increase in the iNOS mRNA level." | 5.34 | Effect of melatonin on altered expression of vasoregulatory genes during hepatic ischemia/reperfusion. ( Choi, SM; Lee, SM; Park, SW, 2007) |
"Melatonin was either infused during both the ischemia and reperfusion periods or only late in the ischemia period and throughout reperfusion." | 5.30 | Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. ( El-Sokkary, GH; Kim, SJ; Manchester, LC; Qi, W; Reiter, RJ; Tan, DX, 1998) |
"These studies demonstrate a significant neuroprotective efficacy of melatonin in term neonatal models of hypoxia-ischaemia, and suggest melatonin is a strong candidate for translation to clinical trials in babies with moderate-severe NE." | 5.22 | Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia. ( Golay, X; Han, HJ; Meehan, C; Miller, SL; Pang, R; Robertson, NJ, 2022) |
" This study aimed to determine the rate of fat peroxidation and tissue protein as an indicator of tissue degradation after ischemia and reperfusion following induction of superior mesenteric artery occlusion in the intestine and to evaluate the protective effect of melatonin as a free radical scavenger and antioxidants in rats." | 4.12 | Protective effect of melatonin as an antioxidant in the intestine of rats with superior mesenteric arterial occlusion. ( Xi, Z; Yu, B; Yuan, X, 2022) |
"The aim of this experiment was to investigate the role of melatonin and spirulina on multiorgan damage induced by ischemia/reperfusion injury (IR) in a rat model." | 4.12 | Protective role of melatonin and spirulina in aortic occlusion-reperfusion model in rats. ( Akduman, H; Dilli, D; Salar, S; Sarı, E; Taşoğlu, İ; Tümer, NB; Yumuşak, N, 2022) |
"Melatonin promptly reversed ischemia-induced sleep disturbances." | 4.02 | Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats. ( Hao, SM; Huang, ZL; Qiu, MH; Qu, WM; Sun, FY; Zhong, ZG, 2021) |
"The current study compared the impact of pretreatment with melatonin and N-acetylcysteine (NAC) on the prevention of rat lung damage following intestinal ischemia-reperfusion (iIR)." | 4.02 | Melatonin can be, more effective than N-acetylcysteine, protecting acute lung injury induced by intestinal ischemia-reperfusion in rat model. ( Brandão, JCM; Camargo, CR; Leite, AA; Marinho, M; Oliveira-Junior, IS; Reiter, RJ; Sakae, TM, 2021) |
" To address this, we investigated the effect of melatonin on ischemia-induced fibrosis." | 3.96 | Melatonin suppresses ischemia-induced fibrosis by regulating miR-149. ( Han, YS; Lee, JH; Lee, SH, 2020) |
"The article studies the effect of melatonin on the intensity of free radical oxidation, the functioning of the enzymatic components of the antioxidant system and their transcriptional regulation in rats with experimental cerebral ischemia/reperfusion of the brain." | 3.91 | Transcriptional Regulation of Antioxidant Enzymes Activity and Modulation of Oxidative Stress by Melatonin in Rats Under Cerebral Ischemia / Reperfusion Conditions. ( de Carvalho, MAP; Kryl'skii, ED; Popova, TN; Razuvaev, GA; Safonova, OA; Stolyarova, AO, 2019) |
" Study groups were formed as follows: (1) control group, (2) ischemia group, (3) selenium + ischemia group, (4) melatonin + ischemia group, and (5) selenium + melatonin + ischemia group." | 3.91 | Effects of Selenium and Melatonin on Ocular Ischemic Syndrome. ( Telek, HH, 2019) |
"Treatment with melatonin reduced/prevented functional and morphological changes induced by chronic ischemia on penile structure and function." | 3.83 | Melatonin Improves Erectile Function in Rats With Chronic Lower Body Ischemia. ( Andersson, KE; Mitsui, T; Nomiya, M; Sawada, N; Takeda, M; Zarifpour, M, 2016) |
"Aortic occlusion, Injury, Ischemia/Reperfusion, Liver, Melatonin." | 3.83 | The protective effect of melatonin on remote organ liver ischemia and reperfusion injury following aortic clamping. ( Adali, F; Bali, A; Celep, RB; Celik, S; Gonul, Y; Koçak, A; Ozkececi, ZT; Ozsoy, M; Tosun, M, 2016) |
"Melatonin exerts a protective effect during hepatic ischemia-reperfusion (I/R) injury through modulation of the apoptotic cell death program." | 3.81 | Melatonin attenuates hepatic ischemia through mitogen-activated protein kinase signaling. ( Gim, SA; Koh, PO, 2015) |
" The rats were then randomly allocated to fracture, fracture-ischemia, fracture- ischemia-melatonin, and fracture-ischemia-CAPE groups." | 3.80 | The effects of melatonin and caffeic acid phenethyl ester (CAPE) on fracture healing under ischemic conditions. ( Aşçı, M; Bostan, B; Erdem, M; Gülabi, D; Güneş, T; Köseoğlu, RD, 2014) |
"This experimental study was designed to produce ischemia-reperfusion (I/R) injury in rat corpus cavernosum by inducing 1 h of priapism and investigating the effects of melatonin on the levels of oxidative injury parameters." | 3.76 | An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis. ( Akbas, A; Atılgan, D; Erdemir, F; Erkorkmaz, U; Parlaktas, BS; Uluocak, N; Yasar, A, 2010) |
"The effect of melatonin on reperfusion arrhythmias and postischemic contractile dysfunction was studied in the isolated rat heart." | 3.73 | Ischemia-reperfusion injury--antiarrhythmic effect of melatonin associated with reduced recovering of contractility. ( Béder, I; Pancza, D; Styk, J; Vazan, R, 2005) |
" Herein, we examined the effect of melatonin on the neutrophil apoptosis in ischemia and reperfusion of the human liver." | 3.72 | Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion. ( Chen, HM; Chen, JC; Chiu, TF; Ng, CJ, 2003) |
"This study was designed to study the effects of Melatonin (Mel) and N-Acetylcystein (NAC) on hepatic ischemia/reperfusion (I/R) injury in rats." | 3.72 | Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. ( Arbak, S; Ayanoğlu-Dülger, G; Ersoy, Y; Kaçmaz, A; Sehirli, AO; Sener, G; Tosun, O, 2003) |
" melatonin (4 + 4 mg/kg, after induction of ischemia and at reperfusion onset) administered either alone or in combination with the thrombolytic tissue-plasminogen activator (t-PA, 10 mg/kg), on cerebral laser Doppler flow (LDF) and ischemic injury were studied after 30 min of middle cerebral artery (MCA) thread occlusion in male C57BL/6 mice." | 3.72 | Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator. ( Hermann, DM; Kilic, E; Kilic, U; Reiter, RJ; Yulug, B, 2004) |
"Pregnancy is well-known to increase the oxidative stress, mainly produced by a normal systemic inflammatory response, which results in high amounts of circulating reactive oxygen species (ROS) and reactive nitrogen species (RNS)." | 2.66 | Oxidative stress: Normal pregnancy versus preeclampsia. ( Abad, C; Chiarello, DI; Marín, R; Mate, A; Rojas, D; Sobrevia, L; Toledo, F; Vázquez, CM, 2020) |
"Melatonin (15 mg/kg) was administered 5 min after HI." | 1.91 | MiR-126 and miR-146a as Melatonin-Responsive Biomarkers for Neonatal Brain Ischemia. ( Albertini, MC; Balduini, W; Buonocore, G; Carloni, S; Dell'Orto, V; Perrone, S; Vanzolini, T; Weiss, MD, 2023) |
"Finally, hemodynamic index changes, infarct size, CK-MB levels, mitochondrial functional endpoints, and expression of mitochondrial biogenesis genes (SIRT-1/PGC-1α/NRF-2/TFAM) were assessed." | 1.91 | Melatonin/nicotinamide mononucleotide/ubiquinol: a cocktail providing superior cardioprotection against ischemia/reperfusion injury in a common co-morbidities modelled rat. ( Badalzadeh, R; Chodari, L; Ghaffari, S; Høilund-Carlsen, PF; Mokhtari, B; Yasami, M, 2023) |
"Melatonin treatment reversed the harmful effects of hyperglycemia on EPC through adenosine monophosphate-activated protein kinase-related mechanisms to increase eNOS phosphorylation and heme oxygenase-1 expression." | 1.72 | Melatonin Improves Ischemia-Induced Circulation Recovery Impairment in Mice with Streptozotocin-Induced Diabetes by Improving the Endothelial Progenitor Cells Functioning. ( Chen, CY; Chou, RH; Huang, HL; Huang, PH; Kuo, CS; Lin, SJ; Tsai, HY; Wei, JH, 2022) |
"Melatonin treatment significantly inhibited the above changes through modulating α7nAChR." | 1.72 | Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss. ( Chen, S; Hu, X; Jin, X; Li, F; Li, H; Li, Y; Liu, W; Sun, Y; Zhang, J; Zhang, X; Zhao, X; Zheng, GQ, 2022) |
"Retinopathy of prematurity is a vision-threatening disease associated with retinal hypoxia-ischemia, leading to the death of retinal neurons and chronic neuronal degeneration." | 1.62 | Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia. ( Cui, K; Huang, R; Liang, X; Lin, J; Liu, Y; Lu, X; Shi, Y; Tang, X; Xu, Y; Ye, D; Yu, S, 2021) |
"Treatment with melatonin rescued replicative senescence by enhancing mitophagy and mitochondrial function through upregulation of heat shock 70 kDa protein 1L (HSPA1L)." | 1.56 | Melatonin suppresses senescence-derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L-mitophagy pathway. ( Lee, JH; Lee, SH; Noh, H; Song, KH; Yoon, YM, 2020) |
"Melatonin is a free radical scavenger and broad-spectrum antioxidant with immunomodulatory effects." | 1.42 | Melatonin prevents lung injury induced by hepatic ischemia-reperfusion through anti-inflammatory and anti-apoptosis effects. ( An, H; Jiang, C; Yang, B; Zhang, H; Zhao, D; Zhou, L, 2015) |
"Melatonin has been widely studied as a protective agent against oxidative stress." | 1.40 | Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression. ( Buendia, I; Cuadrado, A; Egea, J; León, R; López, MG; Negredo, P; Parada, E; Romero, A, 2014) |
"Melatonin augmented the increase in the eNOS mRNA level, whereas it reduced the increase in the iNOS mRNA level." | 1.34 | Effect of melatonin on altered expression of vasoregulatory genes during hepatic ischemia/reperfusion. ( Choi, SM; Lee, SM; Park, SW, 2007) |
"Melatonin treatment in I/R rats reversed these changes (P < 0." | 1.32 | Melatonin ameliorates oxidative organ damage induced by acute intra-abdominal compartment syndrome in rats. ( Kaçmaz, A; Ozkan, S; Sener, G; Tilki, M; User, Y; Yeğen, BC, 2003) |
"Melatonin and PGE1 were found to be effective in reducing the hepatic ischaemia reperfusion damage in rats." | 1.32 | The effects of melatonin and prostaglandin E1 analogue on experimental hepatic ischaemia reperfusion damage. ( Akkus, MA; Aygen, E; Bülbüller, N; Cetinkaya, Z; Cifter, C; Dogru, O; Ilhan, YS, 2003) |
"Melatonin was either infused during both the ischemia and reperfusion periods or only late in the ischemia period and throughout reperfusion." | 1.30 | Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. ( El-Sokkary, GH; Kim, SJ; Manchester, LC; Qi, W; Reiter, RJ; Tan, DX, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (4.92) | 18.2507 |
2000's | 13 (21.31) | 29.6817 |
2010's | 22 (36.07) | 24.3611 |
2020's | 23 (37.70) | 2.80 |
Authors | Studies |
---|---|
Sarı, E | 1 |
Dilli, D | 1 |
Taşoğlu, İ | 1 |
Akduman, H | 1 |
Yumuşak, N | 1 |
Tümer, NB | 1 |
Salar, S | 1 |
Hao, SM | 1 |
Zhong, ZG | 1 |
Qu, WM | 1 |
Huang, ZL | 1 |
Sun, FY | 1 |
Qiu, MH | 1 |
Hosseinzadeh, MH | 1 |
Goodarzi, A | 1 |
Malekan, M | 1 |
Ebrahimzadeh, MA | 1 |
Pang, R | 2 |
Han, HJ | 1 |
Meehan, C | 1 |
Golay, X | 1 |
Miller, SL | 1 |
Robertson, NJ | 2 |
Yuan, X | 1 |
Xi, Z | 1 |
Yu, B | 1 |
Bseiso, EA | 1 |
AbdEl-Aal, SA | 1 |
Nasr, M | 1 |
Sammour, OA | 1 |
El Gawad, NAA | 1 |
Peña-Mercado, E | 1 |
Garcia-Lorenzana, M | 1 |
Huerta-Yepez, S | 1 |
Cruz-Ledesma, A | 1 |
Beltran-Vargas, NE | 1 |
Coskun, A | 1 |
Yegen, C | 1 |
Arbak, S | 2 |
Attaallah, W | 1 |
Gunal, O | 1 |
Elmas, MA | 1 |
Ucal, Y | 1 |
Can, O | 1 |
Baş, B | 1 |
Yildirim, Z | 1 |
Seckin, I | 1 |
Demirci, S | 1 |
Serteser, M | 1 |
Ozpinar, A | 1 |
Belce, A | 1 |
Basdemir, G | 1 |
Moldur, DE | 1 |
Derelioglu, EI | 1 |
Yozgatli, TK | 1 |
Erdemgil, Y | 1 |
Unsal, I | 1 |
Zhang, T | 1 |
Ouyang, H | 1 |
Liu, S | 1 |
Xiong, L | 1 |
Zhong, Z | 1 |
Wang, Q | 1 |
Qiu, Z | 1 |
Ding, Y | 1 |
Zhou, W | 1 |
Wang, X | 1 |
Kuo, CS | 1 |
Chen, CY | 1 |
Huang, HL | 1 |
Tsai, HY | 1 |
Chou, RH | 1 |
Wei, JH | 1 |
Huang, PH | 1 |
Lin, SJ | 1 |
Luchetti, F | 3 |
Nasoni, MG | 3 |
Burattini, S | 3 |
Mohammadi, A | 3 |
Pagliarini, M | 3 |
Canonico, B | 3 |
Ambrogini, P | 3 |
Balduini, W | 4 |
Reiter, RJ | 7 |
Carloni, S | 4 |
Mokhtari, B | 1 |
Høilund-Carlsen, PF | 1 |
Chodari, L | 1 |
Yasami, M | 1 |
Badalzadeh, R | 1 |
Ghaffari, S | 1 |
Yang, H | 1 |
Zhang, Z | 1 |
Ding, X | 1 |
Jiang, X | 1 |
Tan, L | 1 |
Lin, C | 1 |
Xu, L | 1 |
Li, G | 1 |
Lu, L | 1 |
Qin, Z | 1 |
Feng, X | 1 |
Li, M | 1 |
Zhang, H | 2 |
Li, S | 1 |
Jin, Y | 1 |
Sabir, H | 1 |
Maes, E | 1 |
Zweyer, M | 1 |
Schleehuber, Y | 1 |
Imam, FB | 1 |
Silverman, J | 1 |
White, Y | 1 |
Pasca, AM | 1 |
Maltepe, E | 1 |
Bernis, ME | 1 |
Albertini, MC | 1 |
Vanzolini, T | 1 |
Perrone, S | 1 |
Weiss, MD | 1 |
Buonocore, G | 1 |
Dell'Orto, V | 1 |
Azedi, F | 1 |
Mehrpour, M | 1 |
Talebi, S | 1 |
Zendedel, A | 1 |
Kazemnejad, S | 1 |
Mousavizadeh, K | 1 |
Beyer, C | 1 |
Zarnani, AH | 1 |
Joghataei, MT | 1 |
Telek, HH | 1 |
Lee, JH | 4 |
Yoon, YM | 2 |
Song, KH | 1 |
Noh, H | 1 |
Lee, SH | 4 |
Han, YS | 3 |
Lin, Y | 1 |
Liu, J | 2 |
Bai, R | 1 |
Shi, J | 1 |
Zhu, X | 1 |
Guo, J | 1 |
Zhang, W | 1 |
Liu, H | 1 |
Liu, Z | 1 |
Huang, R | 1 |
Xu, Y | 1 |
Lu, X | 1 |
Tang, X | 1 |
Lin, J | 1 |
Cui, K | 1 |
Yu, S | 1 |
Shi, Y | 1 |
Ye, D | 1 |
Liu, Y | 1 |
Liang, X | 1 |
Leite, AA | 1 |
Brandão, JCM | 1 |
Sakae, TM | 1 |
Marinho, M | 1 |
Camargo, CR | 1 |
Oliveira-Junior, IS | 1 |
Chen, S | 1 |
Sun, Y | 1 |
Li, F | 1 |
Zhang, X | 2 |
Hu, X | 1 |
Zhao, X | 1 |
Li, Y | 1 |
Li, H | 1 |
Zhang, J | 1 |
Liu, W | 1 |
Zheng, GQ | 1 |
Jin, X | 1 |
Lee, FY | 1 |
Sun, CK | 2 |
Sung, PH | 2 |
Chen, KH | 1 |
Chua, S | 1 |
Sheu, JJ | 1 |
Chung, SY | 1 |
Chai, HT | 1 |
Chen, YL | 1 |
Huang, TH | 1 |
Huang, CR | 1 |
Li, YC | 1 |
Luo, CW | 1 |
Yip, HK | 2 |
Jung, SK | 1 |
Chiarello, DI | 1 |
Abad, C | 1 |
Rojas, D | 1 |
Toledo, F | 1 |
Vázquez, CM | 1 |
Mate, A | 1 |
Sobrevia, L | 1 |
Marín, R | 1 |
Kryl'skii, ED | 1 |
Popova, TN | 1 |
Safonova, OA | 1 |
Stolyarova, AO | 1 |
Razuvaev, GA | 1 |
de Carvalho, MAP | 1 |
Ritzenthaler, T | 1 |
Lhommeau, I | 1 |
Douillard, S | 1 |
Cho, TH | 1 |
Brun, J | 1 |
Patrice, T | 1 |
Nighoghossian, N | 1 |
Claustrat, B | 1 |
Hemadi, M | 1 |
Shokri, S | 1 |
Moramezi, F | 1 |
Nikbakht, R | 1 |
Sobhani, A | 1 |
Parada, E | 1 |
Buendia, I | 1 |
León, R | 1 |
Negredo, P | 1 |
Romero, A | 1 |
Cuadrado, A | 1 |
López, MG | 1 |
Egea, J | 1 |
Erdem, M | 1 |
Gülabi, D | 1 |
Aşçı, M | 1 |
Bostan, B | 1 |
Güneş, T | 1 |
Köseoğlu, RD | 1 |
Griebling, TL | 1 |
Wang, F | 1 |
Zhou, H | 1 |
Du, Z | 1 |
Chen, X | 1 |
Zhu, F | 1 |
Wang, Z | 1 |
Zhang, Y | 1 |
Lin, L | 1 |
Qian, M | 1 |
Li, X | 1 |
Hao, A | 1 |
Halladin, NL | 1 |
Gim, SA | 1 |
Koh, PO | 1 |
Zhou, L | 1 |
Zhao, D | 1 |
An, H | 1 |
Jiang, C | 1 |
Yang, B | 1 |
Sawada, N | 2 |
Nomiya, M | 2 |
Zarifpour, M | 2 |
Mitsui, T | 1 |
Takeda, M | 1 |
Andersson, KE | 2 |
Ozsoy, M | 1 |
Gonul, Y | 1 |
Ozkececi, ZT | 1 |
Bali, A | 1 |
Celep, RB | 1 |
Koçak, A | 1 |
Adali, F | 1 |
Tosun, M | 1 |
Celik, S | 1 |
Lee, MS | 1 |
Yin, TC | 1 |
Chiang, JY | 1 |
Uluocak, N | 1 |
Atılgan, D | 1 |
Erdemir, F | 1 |
Parlaktas, BS | 1 |
Yasar, A | 1 |
Erkorkmaz, U | 1 |
Akbas, A | 1 |
Deykun, K | 1 |
Pometlova, M | 1 |
Schutova, B | 1 |
Mares, J | 1 |
Tao, RR | 1 |
Huang, JY | 1 |
Shao, XJ | 1 |
Ye, WF | 1 |
Tian, Y | 1 |
Liao, MH | 1 |
Fukunaga, K | 1 |
Lou, YJ | 1 |
Han, F | 1 |
Lu, YM | 1 |
Burmeister, DM | 1 |
Campeau, L | 1 |
Yamaguchi, O | 1 |
Jaworek, J | 1 |
Leja-Szpak, A | 1 |
Bonior, J | 1 |
Nawrot, K | 1 |
Tomaszewska, R | 1 |
Stachura, J | 1 |
Sendur, R | 1 |
Pawlik, W | 1 |
Brzozowski, T | 1 |
Konturek, SJ | 1 |
Pei, Z | 1 |
Cheung, RT | 1 |
Chen, JC | 1 |
Ng, CJ | 1 |
Chiu, TF | 1 |
Chen, HM | 1 |
Sener, G | 2 |
Tosun, O | 1 |
Sehirli, AO | 1 |
Kaçmaz, A | 2 |
Ersoy, Y | 1 |
Ayanoğlu-Dülger, G | 1 |
Okatani, Y | 1 |
Wakatsuki, A | 1 |
Enzan, H | 1 |
Miyahara, Y | 1 |
User, Y | 1 |
Ozkan, S | 1 |
Tilki, M | 1 |
Yeğen, BC | 1 |
Bülbüller, N | 1 |
Cetinkaya, Z | 1 |
Akkus, MA | 1 |
Cifter, C | 1 |
Ilhan, YS | 1 |
Dogru, O | 1 |
Aygen, E | 1 |
Kilic, E | 1 |
Kilic, U | 1 |
Yulug, B | 1 |
Hermann, DM | 1 |
Ates, B | 1 |
Yilmaz, I | 1 |
Geckil, H | 1 |
Iraz, M | 1 |
Birincioglu, M | 1 |
Fiskin, K | 1 |
Barun, S | 1 |
Ekingen, G | 1 |
Mert Vural, I | 1 |
Türkyilmaz, Z | 1 |
Başaklar, C | 1 |
Kale, N | 1 |
Sevim Ercan, Z | 1 |
Sarioğlu, Y | 1 |
Vazan, R | 1 |
Pancza, D | 1 |
Béder, I | 1 |
Styk, J | 1 |
Park, SW | 1 |
Choi, SM | 1 |
Lee, SM | 1 |
Mias, C | 1 |
Trouche, E | 1 |
Seguelas, MH | 1 |
Calcagno, F | 1 |
Dignat-George, F | 1 |
Sabatier, F | 1 |
Piercecchi-Marti, MD | 1 |
Daniel, L | 1 |
Bianchi, P | 1 |
Calise, D | 1 |
Bourin, P | 1 |
Parini, A | 1 |
Cussac, D | 1 |
Cazevieille, C | 1 |
Osborne, NN | 1 |
Tan, DX | 1 |
Manchester, LC | 1 |
Qi, W | 1 |
Kim, SJ | 1 |
El-Sokkary, GH | 1 |
Lopez-Gonzalez, MA | 1 |
Guerrero, JM | 1 |
Rojas, F | 1 |
Osuna, C | 1 |
Delgado, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Determine the Effects of Selenium and Melatonin on Ocular Ischemic Syndrome[NCT04005222] | Early Phase 1 | 28 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
The Effect of Remote Ischemic Preconditioning on the Postoperative Liver Function in Living Donor Hepatectomy: a Randomized Clinical Trial[NCT03386435] | 160 participants (Actual) | Interventional | 2016-08-22 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The incidence of delayed recovery of hepatic function (DRHF) were used as surrogate parameters indicating the possible benefits of RIPC. DRHF was defined based on a proposal by the International Study Group of Liver Surgery, as follows: an impaired ability of the liver to maintain its synthetic, excretory, and detoxifying functions, which are characterized by an increased PT INR and concomitant hyperbilirubinemia (considering the normal limits of the local laboratory) on or after postoperative day 5. The normal upper limits of PT and bilirubin in our institutional laboratory were 1.30 INR and 1.2 mg/dL, respectively. If either the PT INR or serum bilirubin concentration was preoperatively elevated, DRHF was defined by an increasing PT INR and increasing serum bilirubin concentration on or after postoperative day 5 (compared with the values of the previous day). (NCT03386435)
Timeframe: postoperative 7 days
Intervention | Participants (Count of Participants) |
---|---|
RIPC | 5 |
Control | 0 |
The serial assessments of routine laboratory values were used as early markers for postoperative liver function. The maximal aspartate aminotransferase level within 7 postoperative days were assessed following RIPC in living donor hepatectomy. (NCT03386435)
Timeframe: within 7 days after operation
Intervention | IU/L (Mean) |
---|---|
RIPC | 145 |
Control | 152 |
The postoperative liver regeneration index (LRI) at postoperative 1 month ) was used as surrogate parameters indicating the possible benefits of RIPC. The LRI was defined as [(VLR - VFLR)/VFLR)] × 100, where VLR is the volume of the liver remnant and VFLR is the volume of the future liver remnant. Liver volume was calculated by CT volumetry using 3-mm-thick dynamic CT images. The graft weight was subtracted from the total liver volume to define the future liver remnant. (NCT03386435)
Timeframe: 1 month
Intervention | percentage of liver volume (Mean) |
---|---|
RIPC | 83.3 |
Control | 94.9 |
The serial assessments of routine laboratory values were used as early markers for postoperative liver function. The maximal alanine aminotransferase level within 7 postoperative days were assessed following RIPC in living donor hepatectomy (NCT03386435)
Timeframe: within 7 days after operation
Intervention | IU/L (Mean) |
---|---|
RIPC | 148 |
Control | 152 |
4 reviews available for melatonin and Ischemia
Article | Year |
---|---|
Efficacy of melatonin in term neonatal models of perinatal hypoxia-ischaemia.
Topics: Animals; Brain Diseases; Humans; Hypothermia, Induced; Hypoxia; Infant, Newborn; Infant, Newborn, Di | 2022 |
Oxidative stress: Normal pregnancy versus preeclampsia.
Topics: Animals; Antioxidants; Endothelial Cells; Female; Free Radicals; Humans; Ischemia; Melatonin; Oxidat | 2020 |
Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.
Topics: Angioplasty, Balloon, Coronary; Animals; Antioxidants; Disease Models, Animal; Female; Humans; Infla | 2015 |
Melatonin enhances survival and preserves functional integrity of stem cells: A review.
Topics: Animals; Antioxidants; Humans; Ischemia; Melatonin; Stem Cell Transplantation; Stem Cells | 2017 |
57 other studies available for melatonin and Ischemia
Article | Year |
---|---|
Protective role of melatonin and spirulina in aortic occlusion-reperfusion model in rats.
Topics: Animals; Antioxidants; Female; Ischemia; Male; Melatonin; Rats; Rats, Wistar; Reperfusion; Reperfusi | 2022 |
Melatonin supplementation in the subacute phase after ischemia alleviates postischemic sleep disturbances in rats.
Topics: Animals; Circadian Rhythm; Dietary Supplements; Ischemia; Male; Melatonin; Rats; Rats, Sprague-Dawle | 2021 |
Melatonin increased hypoxia-inducible factor (HIF) by inhibiting prolyl hydroxylase: A hypothesis for treating anaemia, ischaemia, and covid-19.
Topics: Anemia; COVID-19; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ischemia; Melatonin; P | 2022 |
Protective effect of melatonin as an antioxidant in the intestine of rats with superior mesenteric arterial occlusion.
Topics: Animals; Antioxidants; Intestines; Ischemia; Male; Malondialdehyde; Melatonin; Rats; Rats, Wistar; R | 2022 |
Nose to brain delivery of melatonin lipidic nanocapsules as a promising post-ischemic neuroprotective therapeutic modality.
Topics: Animals; Brain; Brain Ischemia; Ischemia; Lipids; Melatonin; Nanocapsules; Sheep | 2022 |
Effect of melatonin on electrical impedance and biomarkers of damage in a gastric ischemia/reperfusion model.
Topics: Animals; Biomarkers; Critical Illness; Electric Impedance; Gastric Mucosa; Ischemia; Male; Melatonin | 2022 |
Melatonin in preservation solutions prevents ischemic injury in rat kidneys.
Topics: Adenosine; Allopurinol; Animals; Glucosamine; Glucose; Glutathione; Histidine; Insulin; Ischemia; Ki | 2022 |
pH/Thermosensitive dual-responsive hydrogel based sequential delivery for site-specific acute limb ischemia treatment.
Topics: Alginates; Allyl Compounds; Cellulose; Delayed-Action Preparations; Humans; Hydrogels; Hydrogen Sulf | 2022 |
Melatonin Improves Ischemia-Induced Circulation Recovery Impairment in Mice with Streptozotocin-Induced Diabetes by Improving the Endothelial Progenitor Cells Functioning.
Topics: Animals; Diabetes Mellitus, Experimental; Endothelial Progenitor Cells; Hindlimb; Humans; Hydrogen P | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin Attenuates Ischemic-like Cell Injury by Promoting Autophagosome Maturation via the Sirt1/FoxO1/Rab7 Axis in Hippocampal HT22 Cells and in Organotypic Cultures.
Topics: Autophagosomes; Forkhead Box Protein O1; Hippocampus; Humans; Ischemia; Melatonin; Sirtuin 1 | 2022 |
Melatonin/nicotinamide mononucleotide/ubiquinol: a cocktail providing superior cardioprotection against ischemia/reperfusion injury in a common co-morbidities modelled rat.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Infarction; Ischemia; Male; Mel | 2023 |
RP58 knockdown contributes to hypoxia-ischemia-induced pineal dysfunction and circadian rhythm disruption in neonatal rats.
Topics: Animals; Animals, Newborn; ARNTL Transcription Factors; Arylalkylamine N-Acetyltransferase; Circadia | 2023 |
Remote ischemic preconditioning-induced late cardioprotection: possible role of melatonin-mitoKATP-H2S signaling pathway.
Topics: Animals; Ischemia; Ischemic Preconditioning; Ischemic Preconditioning, Myocardial; KATP Channels; Me | 2023 |
Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia-ischemia in newborn rats: a multi-drug randomized controlled screening trial.
Topics: Allopurinol; Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Brain Injuries; Caffeine; Clemas | 2023 |
MiR-126 and miR-146a as Melatonin-Responsive Biomarkers for Neonatal Brain Ischemia.
Topics: Animals; Animals, Newborn; Biomarkers; Brain; Brain Injuries; Female; Hypoxia-Ischemia, Brain; Ische | 2023 |
Melatonin regulates neuroinflammation ischemic stroke damage through interactions with microglia in reperfusion phase.
Topics: Animals; Brain Ischemia; Inflammation; Ischemia; Male; Melatonin; Microglia; Neuroimmunomodulation; | 2019 |
Effects of Selenium and Melatonin on Ocular Ischemic Syndrome.
Topics: Aged; Aged, 80 and over; Eye; Female; Glutathione; Humans; Ischemia; Male; Malondialdehyde; Melatoni | 2019 |
Melatonin suppresses senescence-derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L-mitophagy pathway.
Topics: Animals; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Gene Knockdown Techniques; HS | 2020 |
Melatonin suppresses ischemia-induced fibrosis by regulating miR-149.
Topics: Animals; Fibrosis; Inflammation; Ischemia; Melatonin; Mice; MicroRNAs; Myoblasts; Peroxisome Prolife | 2020 |
Mitochondria-Inspired Nanoparticles with Microenvironment-Adapting Capacities for On-Demand Drug Delivery after Ischemic Injury.
Topics: Drug Delivery Systems; Humans; Ischemia; Melatonin; Mitochondria; Nanoparticles; Pharmaceutical Prep | 2020 |
Melatonin protects inner retinal neurons of newborn mice after hypoxia-ischemia.
Topics: Animals; Animals, Newborn; Hypoxia; Ischemia; Melatonin; Mice; Mice, Inbred C57BL; Neuroprotective A | 2021 |
Melatonin can be, more effective than N-acetylcysteine, protecting acute lung injury induced by intestinal ischemia-reperfusion in rat model.
Topics: Acetylcysteine; Acute Lung Injury; Animals; Ischemia; Melatonin; Rats; Rats, Wistar; Reperfusion; Re | 2021 |
Modulation of α7nAchR by Melatonin Alleviates Ischemia and Reperfusion-Compromised Integrity of Blood-Brain Barrier Through Inhibiting HMGB1-Mediated Microglia Activation and CRTC1-Mediated Neuronal Loss.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Blood-Brain Barrier; HMGB1 Protein; Ischemia; Isch | 2022 |
Daily melatonin protects the endothelial lineage and functional integrity against the aging process, oxidative stress, and toxic environment and restores blood flow in critical limb ischemia area in mice.
Topics: Animals; Cellular Senescence; Endothelial Cells; Hindlimb; Ischemia; Male; Melatonin; Mice; Oxidativ | 2018 |
Melatonin protects mesenchymal stem cells from autophagy-mediated death under ischaemic ER-stress conditions by increasing prion protein expression.
Topics: Animals; Antioxidants; Autophagy; Cells, Cultured; Endoplasmic Reticulum Stress; Hindlimb; Ischemia; | 2019 |
Transcriptional Regulation of Antioxidant Enzymes Activity and Modulation of Oxidative Stress by Melatonin in Rats Under Cerebral Ischemia / Reperfusion Conditions.
Topics: Animals; Antioxidants; Brain; Brain Ischemia; Free Radicals; Ischemia; Male; Melatonin; Nerve Tissue | 2019 |
Dynamics of oxidative stress and urinary excretion of melatonin and its metabolites during acute ischemic stroke.
Topics: Aged; Comorbidity; Female; France; Humans; Ischemia; Male; Melatonin; Metabolism; Middle Aged; Oxida | 2013 |
Potential use of melatonin supplementation to protect vitrified testicular grafts from hypoxic-ischaemic damage.
Topics: Animals; Culture Media; Hypoxia; In Situ Nick-End Labeling; In Vitro Techniques; Ischemia; Male; Mel | 2014 |
Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO-1 overexpression.
Topics: Animals; CA1 Region, Hippocampal; Cell Line, Tumor; Cells, Cultured; Glucose; Heme Oxygenase-1; Huma | 2014 |
The effects of melatonin and caffeic acid phenethyl ester (CAPE) on fracture healing under ischemic conditions.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Fracture Fixation, Intramedullary; Fra | 2014 |
Re: Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function.
Topics: Animals; Ischemia; Male; Melatonin; Urinary Bladder | 2014 |
Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Hypoxia; Cell Survival; Cellular Mic | 2015 |
Melatonin attenuates hepatic ischemia through mitogen-activated protein kinase signaling.
Topics: Animals; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Ischemia; Liver; M | 2015 |
Melatonin prevents lung injury induced by hepatic ischemia-reperfusion through anti-inflammatory and anti-apoptosis effects.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Cytoki | 2015 |
Melatonin Improves Erectile Function in Rats With Chronic Lower Body Ischemia.
Topics: Animals; Antioxidants; Atherosclerosis; Cholesterol, Dietary; Chronic Disease; Disease Models, Anima | 2016 |
The protective effect of melatonin on remote organ liver ischemia and reperfusion injury following aortic clamping.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aorta, Abdominal; Aspartate A | 2016 |
Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression.
Topics: Animals; Antioxidants; Apoptosis; Blotting, Western; Cell Proliferation; Disease Models, Animal; Flo | 2017 |
An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis.
Topics: Animals; Antioxidants; Disease Models, Animal; Ischemia; Male; Melatonin; Penis; Priapism; Rats; Rat | 2010 |
Modulations of behavioral consequences of minor cortical ischemic lesion by application of free radicals scavengers.
Topics: Animals; Behavior, Animal; Brain Ischemia; Cognition; Cyclic N-Oxides; Feedback, Sensory; Free Radic | 2011 |
Ischemic injury promotes Keap1 nitration and disturbance of antioxidative responses in endothelial cells: a potential vasoprotective effect of melatonin.
Topics: Analysis of Variance; Antioxidants; Cell Line; Endothelial Cells; Glucose; Histocytochemistry; Human | 2013 |
Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function.
Topics: Animals; Chronic Disease; Ischemia; Male; Melatonin; Rats; Rats, Sprague-Dawley; Urinary Bladder | 2013 |
Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion.
Topics: Adjuvants, Immunologic; Animals; Ceruletide; Interleukin-10; Ischemia; Male; Melatonin; Pancreas; Pa | 2003 |
Melatonin protects SHSY5Y neuronal cells but not cultured astrocytes from ischemia due to oxygen and glucose deprivation.
Topics: Animals; Astrocytes; Cell Death; Cell Hypoxia; Cells, Cultured; Dose-Response Relationship, Drug; Gl | 2003 |
Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion.
Topics: Apoptosis; CD18 Antigens; Cells, Cultured; Cholecystectomy, Laparoscopic; Hepatectomy; Humans; Ische | 2003 |
Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion.
Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Female; Free Radical Scavengers; Glutathione; Isc | 2003 |
Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver.
Topics: Animals; Ischemia; Liver; Male; Melatonin; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Reperfus | 2003 |
Melatonin ameliorates oxidative organ damage induced by acute intra-abdominal compartment syndrome in rats.
Topics: Abdomen; Animals; Compartment Syndromes; Free Radical Scavengers; Glutathione; Ischemia; Lipid Perox | 2003 |
The effects of melatonin and prostaglandin E1 analogue on experimental hepatic ischaemia reperfusion damage.
Topics: Alanine Transaminase; Alprostadil; Animals; Antioxidants; Aspartate Aminotransferases; Erythrocytes; | 2003 |
Melatonin reduces disseminate neuronal death after mild focal ischemia in mice via inhibition of caspase-3 and is suitable as an add-on treatment to tissue-plasminogen activator.
Topics: Animals; Brain Ischemia; Caspase 3; Caspase Inhibitors; Cell Death; Coronary Disease; Corpus Striatu | 2004 |
Protective role of melatonin given either before ischemia or prior to reperfusion on intestinal ischemia-reperfusion damage.
Topics: Animals; Antioxidants; Catalase; Glutathione Peroxidase; Intestinal Mucosa; Intestines; Ischemia; Li | 2004 |
The effects of melatonin on electrical field stimulation-evoked biphasic twitch responses in the ipsilateral and contralateral rat vasa deferentia after unilateral testicular torsion/detorsion.
Topics: Animals; Antioxidants; Electric Stimulation; Ischemia; Male; Melatonin; Muscle Contraction; Rats; Ra | 2005 |
Ischemia-reperfusion injury--antiarrhythmic effect of melatonin associated with reduced recovering of contractility.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Free Radical Scavengers; Ischemia; Male; Mela | 2005 |
Effect of melatonin on altered expression of vasoregulatory genes during hepatic ischemia/reperfusion.
Topics: Alanine Transaminase; Animals; Carbon Monoxide; Gene Expression Regulation; Heme Oxygenase-1; Ischem | 2007 |
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney.
Topics: Animals; Bone Marrow Cells; Cell Proliferation; Cell Survival; Fibroblast Growth Factor 2; Hepatocyt | 2008 |
Retinal neurones containing kainate receptors are influenced by exogenous kainate and ischaemia while neurones lacking these receptors are not -- melatonin counteracts the effects of ischaemia and kainate.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Cells, Cultured; Excitatory Amino Acid Antagonists; I | 1997 |
Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin.
Topics: Animals; Antioxidants; Arrhythmias, Cardiac; Ascorbic Acid; Dose-Response Relationship, Drug; Free R | 1998 |
Melatonin and other antioxidants prolong the postmortem activity of the outer hair cells of the organ of Corti: its relation to the type of death.
Topics: Animals; Antioxidants; Female; Hair Cells, Auditory, Outer; Ischemia; Melatonin; Otoacoustic Emissio | 1999 |